5 completed, 1 active not recruiting. 4 Phase 3, 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Completed 4 |
| Phase 1 | 1 | Active not recruiting 1 |
| Phase 2 | 1 | Completed 1 |
Follow Glenmark Specialty S.A.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of GRC 54276 in Participants With Advanced Solid Tumors and Lymphomas. GRC 54276, GRC 54276 + Pembrolizumab, GRC 54276 + Atezolizumab - Advanced Solid Tumor, Lymphoma | Phase 1 | Active not recruiting | Glenmark Specialty S.A. | 320 | 2022-06-28 | 2024-07-22 |
| Efficacy and Safety of GSP 301 Nasal Spray in Children (Aged 6 to Under 12 Years) With Seasonal Allergic Rhinitis (SAR) GSP 301 NS, GSP 301 Placebo NS - Seasonal Allergic Rhinitis (SAR) | Phase 3 | Completed | Glenmark Specialty S.A. | 446 | 2018-03-16 | 2019-10-08 |
| Pharmacodynamic and Pharmacokinetic Dose Ranging Study of Tiotropium Bromide Administered Via Inhalation Solution in Patients With Chronic Obstructive Pulmonary Disease (COPD) GSP304 (tiotropium bromide) Inhalation Solution, GSP304 Placebo Inhalation Solution, Spiriva® Respimat® inhalation spray - Mild to Moderate Chronic Obstructive Pulmonary Disease (COPD) | Phase 2 | Completed | Glenmark Specialty S.A. | 155 | 2017-03-24 | 2019-08-01 |
| Efficacy and Safety of GSP 301 Nasal Spray in the Treatment of Seasonal Allergic Rhinitis (SAR) GSP 301 NS, GOM-NS, GMM-2 NS - Seasonal Allergic Rhinitis (SAR) | Phase 3 | Completed | Glenmark Specialty S.A. | 1176 | 2016-08-01 | 2018-04-06 |
| Long Term Safety and Efficacy of Fixed Dose Combination GSP 301 Nasal Spray (NS) in the Treatment of Perennial Allergic Rhinitis (PAR) GSP 301 NS, GSP 301 Placebo NS pH 3.7, GSP 301 Placebo NS pH 7.0 - Perennial Allergic Rhinitis | Phase 3 | Completed | Glenmark Specialty S.A. | 601 | 2016-04-01 | 2020-02-26 |
| Efficacy and Safety of Fixed Dose Combination GSP 301 Nasal Spray (NS) in the Treatment of Seasonal Allergic Rhinitis (SAR) GSP 301 NS, Olopatadine HCl NS, Mometasone furoate NS - Seasonal Allergic Rhinitis | Phase 3 | Completed | Glenmark Specialty S.A. | 1180 | 2016-03-01 | 2018-09-25 |
Rhinitis, Allergic, Seasonal (3) · Lymphoma (1) · Rhinitis, Allergic, Perennial (1)
Tiotropium Bromide (1) · atezolizumab (1) · pembrolizumab (1)
United States (6) · India (1)
Sudeesh Tantry, PhD (3) · Cynthia Caracta, MD FCCP (1) · Sudeesh Tantry (1) · Veena Gupta (1)